Raimundo
Raimundo Cabrera Perez, Santa Cruz De Tenerife ES
Patent application number | Description | Published |
---|---|---|
20150030706 | USE OF ESSENTIAL OILS, SUPERCRITICAL EXTRACTS AND AQUEOUS RESIDUES GENERATED DURING A PROCESS FOR OBTAINING ORGANIC EXTRACTS FROM THE ARTEMISIA ABSINTHIUM L. PLANT - The present invention starts with a method for obtaining organic extracts of the | 01-29-2015 |
Raimundo Mirisola, London GB
Patent application number | Description | Published |
---|---|---|
20110197220 | CUSTOMIZED TELEVISION ADVERTISING - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for providing customized television advertisements. In one aspect, television advertising templates are used for generating customized television advertisements. The television advertisement templates include targeting criteria specifying targeting conditions for the television advertising template, which are conditions for selecting the television advertisement template for an advertisement availability, and content selection criteria specifying availability content associated with an advertisement availability for use in selecting variable advertisement content elements for inclusion in a customized television advertisement generated from the television advertising template. The variable advertisement content elements can include video elements, audio elements, and text elements. | 08-11-2011 |
20120084801 | System and Method for Providing Real Time Television Viewing Information and Popularity to Viewers - A method providing real-time popularity information regarding TV programs, performed during a short period of time at a server with one or more processors and memory. The server receives current TV viewing information from a plurality of distinct households. The current TV viewing information for a household identifies one or more TV programs that are now showing at the household. The server aggregates the current TV viewing information, thereby identifying one or more currently popular TV programs. The currently popular TV programs have more household viewers than less popular TV programs. The server receives a request from a household seeking identification of currently popular TV programs. The server selects one or more of the currently popular TV programs identified during the aggregation, and sends information to the household. The information identifies the selected one or more currently popular TV programs. | 04-05-2012 |
20120084828 | System and Method for Linking Web Browsing with Television Viewing - A server receives an IP address associated with an account of a TV subscriber using a TV service. The IP address is associated with a set top box employed by the TV subscriber to display TV content provided by the TV service. The IP address is also associated with computers of a household corresponding to the TV subscriber. The computers use web browsers to view Internet content. The server receives information on TV viewing, including the IP address. The server also receives information on web browsing activity in the household associated with the IP address. The information includes the IP address. The server maintains a TV log of the TV viewing and maintains an Internet log of the web browsing activity in the household associated with the IP address. The server associates entries in the TV log with entries in the Internet log(using IP address), and stores the associations. | 04-05-2012 |
20150089522 | METHOD AND SYSTEM FOR PROVIDING EFFICIENT AND ACCURATE ESTIMATES OF TV VIEWERSHIP RATINGS - A method for providing efficient and accurate estimates of TV viewership ratings through a distributed computer system that includes multiple computers is disclosed. The method includes: receiving a query from a client at the distributed computer system; dynamically selecting one or more computers according to a predefined sharding function; at each of the selected computers, determining a count of qualified event records that satisfy the query; aggregating the respective counts of qualified event records determined by the selected computers; statistically projecting the aggregated count of qualified event records into an estimated total count of qualified event records on the distributed computer system; and returning the estimated total count of qualified event records to the requesting client. | 03-26-2015 |
20150089523 | METHOD AND SYSTEM FOR COLLECTING AND MANAGING TV VIEWERSHIP DATA - A computer-implemented method for collecting and managing TV viewership data from multiple TV metering data providers is disclosed. The method includes: receiving an event log file at a distributed computer system that includes multiple computers; dynamically selecting one or more computers according to a predefined sharding function; at each of the selected computers: allocating a set of compressed event records, which corresponds to a subset of the event log file, at predetermined locations within the memory of the computer; and in accordance with a predefined schedule, replicating the compressed event records from a respective one of the selected computers to one or more other computers of the distributed system such that there are at least two replicas of any event record on at least two computers of the distributed computer system. | 03-26-2015 |
Raimundo Mirisola, Zug Zug CH
Patent application number | Description | Published |
---|---|---|
20150178769 | SYSTEMS AND METHODS FOR AUDIENCE MEASUREMENT - To provide secure single-source panel audience measurement data while providing confidentiality and security of panel membership, an audience measurement server may capture content identifiers and client identifiers of devices receiving content. A panel provider may generate a probabilistic data structure via a hash of the client identifiers. The audience measurement server may utilize the filter array to extract a subset of measurement data including the data of the panel members, as well as data of some non-panel members as false positives, without being able to distinguish between the members and non-members. The audience measurement server may encrypt the extracted subset of data with each client identifier corresponding to an item of data as a key, and send the encrypted data to the panel provider, thus including both panel and some non-panel data, with the panel provider only able to decrypt data corresponding to its own panel members. | 06-25-2015 |
Raimundo Mirisola, Zug CH
Patent application number | Description | Published |
---|---|---|
20150067869 | PROTECTING PRIVACY VIA A GATEWAY - A system and methods for protecting privacy via a gateway are provided. The system includes a data store comprising a computer readable medium storing a program of instructions for performing the protection of privacy via the gateway; a processor that executes the program of instructions; an event detection unit to detect an event behind the gateway; a correlation unit to detect a source associated with the detected event; a semi-stable identification unit to assign a semi-stable identification for the associated source with the detected event; a vector assigning unit to assign a vector to data associated with the semi-stable identification, the vector being related to the source independent any personal identification information (PII); and a communication unit to transmit the vector to instigate an action. | 03-05-2015 |
Raimundo Pontes Filho, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20130204609 | LANGUAGE INDEPENDENT PROBABILISTIC CONTENT MATCHING - Content is received and compared against rules for identifying a type of content. Each rule has both segmented and unsegmented patterns. The content is matched against the patterns and assigned a confidence score that is higher if the content matches a segmented pattern and lower if the content matches an unsegmented pattern. | 08-08-2013 |
Raimundo Ubieta Gomez, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20090215730 | Antineoplastic compounds and pharmaceutical compositions thereof - Chemical compounds derived by in silico molecular modelling, having a well defined structure suitable for the blocking of the phosphorylation event, through the specific interaction of the chemical with the Casein Kinase 2 enzyme substrate phosphorylation domain or it's neighbourhood. This invention comprises also the pharmaceutical compositions containing such compounds, and their use in the preparation of medicines or agents for the treatment of diseases or conditions related with neoplasic processes. | 08-27-2009 |
20090221508 | IMMUNOMODULATORY AND ANTI-TUMOUR PEPTIDES - The present invention is related to the development of peptides derived from the sequence HYRIKPTFRRLKWKKYKGKFW, showing aminoacids substitutions, these peptides unable to bind to the lipopolysaccharide and bearing anti-tumoral and immunomodulatory capacities. These peptides alone or in combination are useful to treat cancer, and also in synergy with conventional therapies. | 09-03-2009 |
20100136062 | USE OF EPIDERMAL GROWTH FACTOR FOR THE MORPHOFUNCTIONAL RESTORATION OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY - The invention relates to human medicine and to the use of epidermal growth factor (EGF) for preparing a pharmaceutical composition which is administered by infiltration into the periphery of nerve ganglia and/or trunks for the morphofunctional restoration of peripheral nerves in painful sensory-motor neuropathy as well as manifestations of ischemic neuritis. The invention also includes a composition containing EGF which can be formulated together with anaesthetics or analgesics or encapsulated in microspheres and to the use thereof for the morphofunctional restoration of peripheral nerves in painful sensitive-motor-type diabetic neuropathy and the manifestations of ischemic neuritis. | 06-03-2010 |
20120308661 | ORALLY ADMINISTRABLE PHARMACEUTICAL PELLET OF EPIDERMAL GROWTH FACTOR - The present invention comprises a pellet of epidermal growth factor and methionine or K | 12-06-2012 |
20140105990 | USE OF EPIDERMAL GROWTH FACTOR FOR THE MORPHOFUNCTIONAL RESTORATION OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY - The present invention is relevant to human medicine, and, in particular, to the use of Epidermal Growth Factor (EGF) in a pharmaceutical composition, said composition is administered through infiltration at the periphery of nerve trunks and/or ganglia, for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as ischemic neuritis. It is also relevant to an EGF containing composition, where this molecule can be formulated together with anesthetic or analgesic drugs, or encapsulated in microspheres, and their use for the morphofunctional restoration of peripheral nerves in painful, sensitive-motor neuropathy, as well as in ischemic neuritis. | 04-17-2014 |
Raimundo Ubieta Gómez, Playa CU
Patent application number | Description | Published |
---|---|---|
20130130971 | Method for Inhibiting HIV Replication in Mammal and Human Cells - The present invention describes a method to inhibit replication of the human immunodeficiency virus (HIV) by negatively modulating or altering the cytoskeleton, more precisely the proteins forming the intermediate cytoskeletal filaments, wherein the said proteins are vimentin and/or keratin-10. The replication of the virus is inhibited in human cells by intervening in the structure of these proteins. The present invention is also related to the use of agents, which comprise peptides and/or interfering RNA and/or lipidic compounds, said agents producing a negative modulation or alteration of the cytoskeleton to prevent or to treat the HIV infection. The invention provides means and methods for altering the cytoskeleton/filament structure of cells, as a result of which the infection of human cells by HIV is disturbed and can even be completely inhibited. The cytoskeleton is altered by reducing the amount of vimentin and/or keratin (e.g. by transcriptional control using interfering RNA) or by using peptides that disrupt the cytoskeleton. | 05-23-2013 |
Raimundo Ubieta Gómez, La Habana CU
Patent application number | Description | Published |
---|---|---|
20120308615 | FORMULATION OF HEPATITIS B VIRUS ANTIGENS FOR CELLULAR STIMULATION FOLLOWED BY THERAPEUTIC IMMUNIZATION - The present invention is related with the field of the therapeutic immunization, specifically with the employment of a new formulation of antigens of the Hepatitis B Virus (HBV) for the cellular stimulation. The formulation is formed by the surface antigens (HBsAg) precipitated in suspension and the nucleocapsid (HBcAg) of the HBV. The formulation contains these antigens like suspended particles of sizes less than 500 nm and higher than 500 nm, in a mixture where the proportion among the particles of the mentioned sizes is among 50%-50% and 80%-20%, respectively. The selection of a range of sizes of particles allows that the levels of stimulation of several cellular types are maximized. Additionally, a cellular stimulation method is described with this formulation, and the later passive immunization of patients with chronic Hepatitis B, based on the maximum stimulation in vivo or in vitro using heterologous or autologous cells (dendritic cells, B cells and macrophages). The cells stimulated with this formulation are transferred to patients chronically infected with the HBV. | 12-06-2012 |
Raimundo Ubieta Gómez, Playa CU
Patent application number | Description | Published |
---|---|---|
20130130971 | Method for Inhibiting HIV Replication in Mammal and Human Cells - The present invention describes a method to inhibit replication of the human immunodeficiency virus (HIV) by negatively modulating or altering the cytoskeleton, more precisely the proteins forming the intermediate cytoskeletal filaments, wherein the said proteins are vimentin and/or keratin-10. The replication of the virus is inhibited in human cells by intervening in the structure of these proteins. The present invention is also related to the use of agents, which comprise peptides and/or interfering RNA and/or lipidic compounds, said agents producing a negative modulation or alteration of the cytoskeleton to prevent or to treat the HIV infection. The invention provides means and methods for altering the cytoskeleton/filament structure of cells, as a result of which the infection of human cells by HIV is disturbed and can even be completely inhibited. The cytoskeleton is altered by reducing the amount of vimentin and/or keratin (e.g. by transcriptional control using interfering RNA) or by using peptides that disrupt the cytoskeleton. | 05-23-2013 |
Raimundo Ubieta Gómez, Ciudad De La Habana CU
Patent application number | Description | Published |
---|---|---|
20120308661 | ORALLY ADMINISTRABLE PHARMACEUTICAL PELLET OF EPIDERMAL GROWTH FACTOR - The present invention comprises a pellet of epidermal growth factor and methionine or K | 12-06-2012 |
Raimundo Ubieta Gómez, La Habana CU
Patent application number | Description | Published |
---|---|---|
20120308615 | FORMULATION OF HEPATITIS B VIRUS ANTIGENS FOR CELLULAR STIMULATION FOLLOWED BY THERAPEUTIC IMMUNIZATION - The present invention is related with the field of the therapeutic immunization, specifically with the employment of a new formulation of antigens of the Hepatitis B Virus (HBV) for the cellular stimulation. The formulation is formed by the surface antigens (HBsAg) precipitated in suspension and the nucleocapsid (HBcAg) of the HBV. The formulation contains these antigens like suspended particles of sizes less than 500 nm and higher than 500 nm, in a mixture where the proportion among the particles of the mentioned sizes is among 50%-50% and 80%-20%, respectively. The selection of a range of sizes of particles allows that the levels of stimulation of several cellular types are maximized. Additionally, a cellular stimulation method is described with this formulation, and the later passive immunization of patients with chronic Hepatitis B, based on the maximum stimulation in vivo or in vitro using heterologous or autologous cells (dendritic cells, B cells and macrophages). The cells stimulated with this formulation are transferred to patients chronically infected with the HBV. | 12-06-2012 |